- Record: found
- Abstract: found
- Article: not found
Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale.
Giuseppe Colucci
1 ,
Vittorio Gebbia ,
Giancarlo Paoletti ,
Francesco Giuliani ,
Michele Caruso ,
Nicola Gebbia ,
Giacomo Cartenì ,
Biagio Agostara ,
Giuseppe Pezzella ,
Luigi Manzione ,
Nicola Borsellino ,
Andrea Misino ,
Sante Romito ,
Ernesto Durini ,
Stefano Cordio ,
Marisa Di Seri ,
Massimo Lopez ,
Evaristo Maiello ,
Severino Montemurro ,
Antonio Cramarossa ,
Vito Lorusso ,
Maurizio Di Bisceglie ,
Maurizio Chiarenza ,
Maria Rosaria Valerio ,
Teresa Guida ,
Vita Leonardi ,
Salvatore Pisconti ,
Gerardo Rosati ,
Francesco Carrozza ,
Giuseppe Nettis ,
Matteo Valdesi ,
Gianfranco Filippelli ,
Santo Fortunato ,
Sergio Mancarella ,
Cosimo Brunetti
Aug 01 2005
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
We performed this phase III study to compare the irinotecan, leucovorin (LV), and fluorouracil (FU) regimen (FOLFIRI) versus the oxaliplatin, LV, and FU regimen (FOLFOX4) in previously untreated patients with advanced colorectal cancer.
Related collections
Author and article information
Comments
Comment on this article
scite_
0
0
0
0
Smart Citations0
0
0
0
Citing PublicationsSupportingMentioningContrasting
See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.